29.81
-0.62 (-2.04%)
| 前收盘价格 | 30.43 |
| 收盘价格 | 30.02 |
| 成交量 | 429,911 |
| 平均成交量 (3个月) | 283,965 |
| 市值 | 1,492,530,048 |
| 价格/销量 (P/S) | 4.86 |
| 股市价格/股市净资产 (P/B) | 4.13 |
| 52周波幅 | |
| 利润日期 | 6 May 2025 - 12 May 2025 |
| 营业毛利率 | -16.47% |
| 营业利益率 (TTM) | -1.67% |
| 稀释每股收益 (EPS TTM) | -1.02 |
| 季度收入增长率 (YOY) | 19.80% |
| 季度盈利增长率 (YOY) | 864.20% |
| 总债务/股东权益 (D/E MRQ) | 119.96% |
| 流动比率 (MRQ) | 4.38 |
| 营业现金流 (OCF TTM) | 26.06 M |
| 杠杆自由现金流 (LFCF TTM) | 38.39 M |
| 资产报酬率 (ROA TTM) | -4.08% |
| 股东权益报酬率 (ROE TTM) | -14.00% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看跌 |
| Biotechnology (全球的) | 混合的 | 看跌 | |
| 股票 | Immunocore Holdings plc | 看跌 | 看跌 |
AIStockmoo 评分
| 分析师共识 | 1.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 1.5 |
| 技术振荡指标 | 0.5 |
| 平均 | 0.25 |
|
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 内部持股比例 | 5.19% |
| 机构持股比例 | 93.89% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 100.00 (HC Wainwright & Co., 235.46%) | 购买 |
| 中 | 50.00 (67.73%) | |
| 低 | 33.00 (Mizuho, 10.70%) | 保留 |
| 平均值 | 57.80 (93.90%) | |
| 总计 | 3 购买, 2 保留 | |
| 平均价格@调整类型 | 27.57 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| JP Morgan | 14 Apr 2025 | 50.00 (67.73%) | 购买 | 26.92 |
| Needham | 10 Apr 2025 | 71.00 (138.18%) | 购买 | 25.82 |
| 12 Mar 2025 | 71.00 (138.18%) | 购买 | 29.05 | |
| Mizuho | 07 Apr 2025 | 33.00 (10.70%) | 保留 | 26.28 |
| HC Wainwright & Co. | 12 Mar 2025 | 100.00 (235.46%) | 购买 | 29.05 |
| 05 Mar 2025 | 100.00 (235.46%) | 购买 | 30.25 | |
| Morgan Stanley | 07 Mar 2025 | 35.00 (17.41%) | 保留 | 29.80 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合